PFS
PDLI

Prospera Financial Services’s PDL BioPharma, Inc. PDLI Stock Holding History

Prospera Financial Services’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-26,850
Closed -$207K – 360
2014
Q4 		$207K Buy
+26,850
New +$212K 0.05% 264
2014
Q2 		– Sell
-16,413
Closed -$136K – 296
2014
Q1 		$136K Buy
+16,413
New +$141K 0.04% 240

Other funds holding PDLI

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Prospera Financial Services's PDLI Position: Q1 2015 in Review

Prospera Financial Services sold out of PDL BioPharma, Inc. (PDLI) in Q1 2015, closing a stake of 26,850 shares — an estimated $207K sold.

Prospera Financial Services first reported a position in PDLI in Q1 2014 and held it in 2 quarters. The position peaked at $207K in Q4 2014. 215 funds tracked by Wall St. Rank hold PDLI as of Q1 2015.

  • Prospera Financial Services reported no remaining PDL BioPharma, Inc. position as of Q1 2015 after selling out during the quarter.
  • Prospera Financial Services sold 26,850 PDL BioPharma, Inc. shares in Q1 2015, an estimated $207K.
  • Prospera Financial Services first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 2 quarters.
  • Prospera Financial Services's PDL BioPharma, Inc. position peaked at $207K in Q4 2014.
  • 215 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2015.

Based on Prospera Financial Services's 13F filing for Q1 2015, filed 22 Apr 2015.